Cashing in on Omicron

Posted On Jan 15, 2022 By Addison Wiggin

As always, it doesn’t matter whether the Omicron panic is warranted or not. All you need to care about is how the change in outlook could affect you and your money. Our science advisor, Ray Blanco, walks us through it in this week’s Session. You’ll learn how Omicron will affect the major vaccine makers’ bottom lines… as well as details on biotech breakthroughs that could become big news as COVID finally fades into the background. Here’s this week’s warm-up to today’s conversation.


Subscribe to Platinum Reserve Today!

From blue chips to penny stocks, income plays to growth opportunities, commodities to techs, ETFs to OTCs, bonds to options — the Agora Financial Platinum Reserve covers it all. You simply cannot find a more comprehensive source of investment analysis and recommendations.

Subscribe Today!